JMP Securities Downgrades Uroplasty (UPI) to Market Perform
UPI Hot Sheet
Rating Summary:3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
JMP Securities downgraded Uroplasty (NASDAQ: UPI) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday, with a 52 week range of $3.73-$9.11.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday, with a 52 week range of $3.73-$9.11.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
- Needham & Company Reiterates a 'Buy' on UQM Technologies (UQM); Increasing EV Adoption
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
